Epitope-specific antibody responses differentiate COVID-19 outcomes and variants of concern
Courtney Voss, Shawn S.‐C. Li(Western University), Shanshan Zhong, Tomonori Kaneko(Western University), Husam Abdoh(Western University), Vipin Bhayana(Western University), Claudio M. Martin(Western University), Marat Slessarev(Western University), T. Skarina(University of Toronto), Douglas D. Fraser(Western University), Benjamin D. Hedley(Western University), Farhad Yusifov(Structural Genomics Consortium), Almagul Seitova(Structural Genomics Consortium), Benjamin Chin‐Yee(London Health Sciences Centre), E. Evdokimova(National Research Tomsk State University), P.J. Stogios(University of Toronto), Pegah Ghiabi(Weill Cornell Medical College in Qatar), Lori E. Lowes(Western University), Ian Chin‐Yee(Western University), Taraneh Haijan(University of Toronto), Suzanne Ackloo, Xuguang Liu(Imperial College London), Ashley Hutchinson(Structural Genomics Consortium), P. Loppnau(University of Toronto), Sally Esmail, Michael J. Knauer(Western University)
Cited by 68
Related Papers
A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical Care
|New England Journal of Medicine|1999|5.2k
DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current -Lactam Antibiotic Doses Sufficient for Critically Ill Patients?
|Clinical Infectious Diseases|2014|1.1k
Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study
|Intensive Care Medicine|2001|984
Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases?
|Critical Care Medicine|2001|597